Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke.

Orosomucoid 2 functional recovery ischemic stroke mitochondrial biogenesis neuroprotection

Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 10 03 2024
revised: 01 09 2024
accepted: 15 09 2024
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 18 9 2024
Statut: aheadofprint

Résumé

Development of functional recovery therapies is critical to reduce the global impact of stroke as the leading cause of long-term disability. Our previous studies found that acute-phase protein orosomucoid (ORM) could provide an up to 6h therapeutic time window to reduce infarct volume in acute ischemic stroke by improving endothelial function. However, its role in neurons and functional recovery post-stroke remains largely unknown. Here, we showed that exogenous ORM administration with initial injection at 0.5h (early) or 12h (delayed) post-MCAO daily for consecutive 7 days significantly decreased infarct area, improved motor and cognitive functional recovery, and promoted mitochondrial biogenesis after MCAO. While neuron-specific knockout of ORM2, a dominant subtype of ORM in the brain, produced opposite effects which could be rescued by exogenous ORM. In vitro, exogenous ORM protected SH-SY5Y cells from OGD-induced damage and promoted mitochondrial biogenesis, while endogenous ORM2 deficiency worsened these processes. Mechanistically, inactivation of CCR5 or AMPK eliminated the protective effects of ORM on neuronal damage and mitochondrial biogenesis. Taken together, our findings demonstrate that ORM, mainly ORM2, is an endogenous regulator of neuronal mitochondrial biogenesis by activating CCR5/AMPK signaling pathway, and might act as a potential therapeutic target for the functional recovery post-stroke.

Identifiants

pubmed: 39293585
pii: S1043-6618(24)00367-0
doi: 10.1016/j.phrs.2024.107422
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107422

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare no conflict of interest. Declaration of Competing Interest We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.

Auteurs

Kai Jing (K)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Ruinan Gu (R)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Feng Chen (F)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Jingjing Wan (J)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Yang Sun (Y)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Pengyue Guo (P)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Fei Chen (F)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Jiayi Feng (J)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China.

Jinmin Guo (J)

Department of Clinical Pharmacy, 960(th) Hospital of Joint Logistic Support Force, Shandong, Jinan, China. Electronic address: gjm90h@126.com.

Xia Liu (X)

Department of Clinical Pharmacy, School of Pharmacy, Second Military Medical University, Shanghai 200082, China. Electronic address: lxflying@aliyun.com.

Classifications MeSH